Stephen D. Griffin, President and CEO at Anika Therapeutics, Inc. (ANIK), bought 12,200 shares at $12.29 ($150K) on 2026-04-30, disclosed to the SEC on 2026-04-30.
CEO Stephen Griffin purchased 12,200 shares for approximately $150,000, marking the largest purchase of his career. This significant insider buying comes as the stock has dropped 19.46% over the past five days, potentially signaling a bottom in the recent volatility.
The stock is currently trading at $12.42, down 19.46% over the last five days and 14.17% over the past month, putting it 22.93% below its 52-week high of $16.12.
CEO Griffin's largest-ever purchase serves as a strong signal of conviction; investors should monitor the Q1 2026 earnings call on April 29, 2026, for updates on commercial channel momentum and pipeline progress.
The stock carries a short interest of 5.46% of the float, and recent reports noted regulatory and pricing challenges in Q4 2025 that could pressure margins.
Something here stands out, but not much.